Correlation Between Zivo Bioscience and Opthea
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Opthea, you can compare the effects of market volatilities on Zivo Bioscience and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Opthea.
Diversification Opportunities for Zivo Bioscience and Opthea
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zivo and Opthea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Opthea go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Opthea
If you would invest 377.00 in Opthea on December 3, 2024 and sell it today you would earn a total of 71.00 from holding Opthea or generate 18.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Zivo Bioscience vs. Opthea
Performance |
Timeline |
Zivo Bioscience |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Opthea |
Zivo Bioscience and Opthea Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zivo Bioscience and Opthea
The main advantage of trading using opposite Zivo Bioscience and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
Opthea vs. Molecular Partners AG | Opthea vs. MediciNova | Opthea vs. Anebulo Pharmaceuticals | Opthea vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |